Adage Capital Partners Gp, L.L.C. Pep Gen Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $56.4 Billion
- Q2 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Pep Gen Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 1,350,000 shares of PEPG stock, worth $6.63 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,350,000
Previous 1,350,000
-0.0%
Holding current value
$6.63 Million
Previous $1.9 Million
21.28%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding PEPG
# of Institutions
52Shares Held
23.6MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA10.7MShares$52.5 Million0.26% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.76MShares$13.5 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.51MShares$7.41 Million0.0% of portfolio
-
Viking Global Investors LP1.48MShares$7.28 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.04MShares$5.1 Million0.0% of portfolio
About PepGen Inc.
- Ticker PEPG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,631,900
- Market Cap $116M
- Description
- PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is a...